NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 175 filers reported holding NOVAVAX INC in Q3 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $241,000 | -56.1% | 131,205 | -55.1% | 0.04% | -28.1% |
| Q3 2018 | $549,000 | -18.2% | 292,125 | -41.7% | 0.06% | -90.4% |
| Q2 2018 | $671,000 | -43.4% | 500,964 | -11.3% | 0.59% | -42.4% |
| Q1 2018 | $1,186,000 | +260.5% | 564,544 | +112.9% | 1.03% | +149.2% |
| Q4 2017 | $329,000 | -6.3% | 265,206 | -14.0% | 0.41% | +778.7% |
| Q3 2017 | $351,000 | +9.0% | 308,286 | +10.1% | 0.05% | -2.1% |
| Q2 2017 | $322,000 | +15.8% | 280,087 | +29.1% | 0.05% | -4.0% |
| Q1 2017 | $278,000 | +12.6% | 216,960 | +10.6% | 0.05% | -32.4% |
| Q4 2016 | $247,000 | +216.7% | 196,162 | +422.4% | 0.07% | +94.7% |
| Q3 2016 | $78,000 | -71.4% | 37,550 | 0.0% | 0.04% | -81.3% |
| Q2 2016 | $273,000 | +71.7% | 37,550 | +22.0% | 0.20% | -7.3% |
| Q1 2016 | $159,000 | -42.0% | 30,787 | -5.9% | 0.22% | -70.9% |
| Q4 2015 | $274,000 | – | 32,714 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
| Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
| BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
| GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
| CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
| Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |